89 related articles for article (PubMed ID: 21414385)
1. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra.
Nicholas AP
Neurosci Lett; 2011 May; 495(1):26-9. PubMed ID: 21414385
[TBL] [Abstract][Full Text] [Related]
2. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of citrullinated proteins in adult rat brain.
Nicholas AP; King JL; Sambandam T; Echols JD; Gupta KB; McInnis C; Whitaker JN
J Comp Neurol; 2003 May; 459(3):251-66. PubMed ID: 12655508
[TBL] [Abstract][Full Text] [Related]
4. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Chu Y; Kompoliti K; Cochran EJ; Mufson EJ; Kordower JH
J Comp Neurol; 2002 Aug; 450(3):203-14. PubMed ID: 12209851
[TBL] [Abstract][Full Text] [Related]
5. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
[TBL] [Abstract][Full Text] [Related]
6. Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex.
Nicholas AP
Neurosci Lett; 2013 Jun; 545():107-11. PubMed ID: 23648390
[TBL] [Abstract][Full Text] [Related]
7. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
8. Akt signal transduction dysfunction in Parkinson's disease.
Timmons S; Coakley MF; Moloney AM; O' Neill C
Neurosci Lett; 2009 Dec; 467(1):30-5. PubMed ID: 19800394
[TBL] [Abstract][Full Text] [Related]
9. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
10. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
[TBL] [Abstract][Full Text] [Related]
11. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis.
Nicholas AP; Sambandam T; Echols JD; Barnum SR
J Comp Neurol; 2005 Jun; 486(3):254-66. PubMed ID: 15844173
[TBL] [Abstract][Full Text] [Related]
12. Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.
Quesada A; Romeo HE; Micevych P
J Comp Neurol; 2007 Jul; 503(1):198-208. PubMed ID: 17480015
[TBL] [Abstract][Full Text] [Related]
13. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
14. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
Anichtchik OV; Rinne JO; Kalimo H; Panula P
Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
[TBL] [Abstract][Full Text] [Related]
15. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
16. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis.
Nicholas AP; Sambandam T; Echols JD; Tourtellotte WW
J Comp Neurol; 2004 May; 473(1):128-36. PubMed ID: 15067723
[TBL] [Abstract][Full Text] [Related]
17. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
18. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
19. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
